by William H. Frishman (Editor), Domenic A. Sica (Editor)

Cardiovascular Pharmacotherapeutics: Abridged and Updated provides current, on-the-spot information on how to use every approved cardiovascular drug in adults and children, and the scientific rationale for their clinical use. A clinical distillation of the editors' comprehensive and highly respected Cardiovascular Pharmacotherapeutics 3rd edition textbook, this treatment-centered abridgement features:

• Indications, contraindications, dosage, side effects, pharmacokinetics, and adverse reactions for all approved cardiovascular drugs, including the newest therapeutic agents to become available
• Rationales and usage guidelines for therapeutic strategies
• Abundant tables and charts that summarize important clinical choices
• Handy appendices that review approved uses of cardiovascular agents and their pharmacologic characteristics
• Considerations for managing patients on multi-drug regimens
• Details on drug-drug interactions
• Updated information on alternative medicine approaches to cardiovascular disease

New with the third edition is an accompanying website, www.cvpct3.com, which highlights advances in cardiovascular drug therapy. Along with providing periodic updates to each chapter, including links to the latest studies, the site reviews cardiovascular drugs newly approved by the FDA for clinical use as well as drugs under investigation. Readers are invited to use the website to communicate directly with the book's authors regarding topics related to cardiovascular drug use.

This book is an abridged and updated version of Cardiovascular Pharmacotherapeutics. Compared to the hardcover 3rd edition, it excludes part 1 (with the exception of the first chapter), includes all of part 2, excludes part 3 (with the exception of chapters 30 and 31), and includes appendices 1 and 2; appendices 3-8 are excluded.

Product Details